[1]
A. M. Sheehy, N. C. Gaddis, J. D. Choi, M. H. Malim, Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein, Nature, vol. 418, Aug. 2002, pp.646-650, doi: 10. 1038/nature00939.
DOI: 10.1038/nature00939
Google Scholar
[2]
R. Suspene, P. Sommer, M. Henry, S. Ferris, D. Guetard, S. Pochet, et al, APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase, Nucleic Acids Res, vol. 32, Mar. 2004, pp.2421-2429.
DOI: 10.1093/nar/gkh554
Google Scholar
[3]
H. Zhang, B. Yang, R. J. Pomerantz, C. Zhang, S. C. Arunachalam, L. Gao, The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA, Nature, vol. 424, Jul. 2003, pp.94-98, doi: 10. 1038/nature01707.
DOI: 10.1038/nature01707
Google Scholar
[4]
K. Shindo, A. Takaori-Kondo, M. Kobayashi, A. Abudu, K. Fukunaga, T. Uchiyama, The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity, J. Biol. Chem, vol. 278, Nov. 2003, pp.44412-44416.
DOI: 10.1074/jbc.c300376200
Google Scholar
[5]
R. Mariani, D. Chen, B. Schrofelbauer, F. Navarro, R. Konig, B. Bollman, et al, Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif, Cell, vol. 114, Jul. 2003, pp.21-31, doi: 10. 1016/S0092-8674(03)00515-4.
DOI: 10.1016/s0092-8674(03)00515-4
Google Scholar
[6]
S. G. Conticello, R. S. Harris, M. S. Neuberger, The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G, Curr. Biol, vol. 13, Nov. 2003, pp.2009-2013, doi: 10. 1016/j. cub. 2003. 10. 034.
DOI: 10.1016/j.cub.2003.10.034
Google Scholar
[7]
R. S. Harris, K. N. Bishop, A. M. Sheehy, H. M. Craig, S. K. Petersen-Mahrt, I. N. Watt, DNA deamination mediates innate immunity to retroviral infection, Cell, vol. 113, Jun. 2003, pp.803-809, doi: 10. 1016/S0092-8674(03)00423-9.
DOI: 10.1016/s0092-8674(03)00423-9
Google Scholar
[8]
D. Lecossier, F. Bouchonnet, F. Clavel, A. J. Hance, Hypermutation of HIV-1 DNA in the absence of the Vif protein, Science, vol. 300, May. 2003, p.1112, doi: 10. 1126/science. 1083338.
DOI: 10.1126/science.1083338
Google Scholar
[9]
B. Mangeat, P. Turelli, G. Caron, M. Friedli, L. Perrin, D. Trono, Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts, Nature, vol. 424, Jul. 2003, pp.99-103, doi: 10. 1038/nature01709.
DOI: 10.1038/nature01709
Google Scholar
[10]
S. Kao, M. A. Khan, E. Miyagi, R. Plishka, A. Buckler-White, K. Strebel, The human immunodeficiency virus Type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity, J. Virol, vol. 77, Nov. 2003, pp.11398-11407, doi: 10. 1128/JVI. 77. 21. 11398-11407. (2003).
DOI: 10.1128/jvi.77.21.11398-11407.2003
Google Scholar
[11]
A. Mehle, B. Strack, P. Ancuta, C. Zhang, M. McPike, D. Gabuzda, Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin–proteasome pathway, J. Biol. Chem, vol. 279, Feb. 2004, pp.7792-7798.
DOI: 10.1074/jbc.m313093200
Google Scholar
[12]
X. Yu, Y. Yu, B. Liu, K. Luo, W. Kong, P. Mao, et al, Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif–Cul5–SCF complex, Science, vol. 302, Nov. 2003, pp.1056-1060, doi: 10. 1126/science. 1089591.
DOI: 10.1126/science.1089591
Google Scholar
[13]
K. Stopak, C. de Noronha, W. Yonemoto, W. C. Greene, HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability, Mol. Cell, vol. 12, Sep. 2003, pp.591-601.
DOI: 10.1016/s1097-2765(03)00353-8
Google Scholar